(BMW) Bayerische Motoren Werke - Ratings and Ratios
Automobiles, Motorcycles, Parts, Leasing, Financing
Dividends
| Dividend Yield | 4.42% |
| Yield on Cost 5y | 8.33% |
| Yield CAGR 5y | 24.47% |
| Payout Consistency | 88.3% |
| Payout Ratio | 37.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 33.4% |
| Value at Risk 5%th | 52.1% |
| Relative Tail Risk | -5.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.88 |
| Alpha | 22.43 |
| CAGR/Max DD | 0.28 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.705 |
| Beta | 0.219 |
| Beta Downside | 0.376 |
| Drawdowns 3y | |
|---|---|
| Max DD | 41.22% |
| Mean DD | 15.95% |
| Median DD | 15.65% |
Description: BMW Bayerische Motoren Werke December 03, 2025
Bayerische Motoren Werke Aktiengesellschaft (BMW) designs, manufactures, and sells premium automobiles and motorcycles worldwide, operating through three segments: Automotive (BMW, MINI, Rolls-Royce), Motorcycles (BMW Motorrad), and Financial Services (including Alphabet fleet leasing, credit, and insurance). All sales are channeled via independent dealerships.
In FY 2023 BMW generated €152.5 billion in revenue with an EBIT margin of 8.6 % and a free-cash-flow conversion of roughly 55 %, reflecting strong pricing power and efficient cost control. The company’s earnings are increasingly tied to the EV transition-its “i” sub-brand delivered a 42 % YoY increase in electric vehicle deliveries, while a 2024 target of 50 % of total sales being electrified underpins future growth. Key macro drivers include European interest-rate trends (affecting financing demand) and Chinese consumer sentiment, which together account for roughly 30 % of total sales.
For a deeper quantitative breakdown of BMW’s valuation multiples and scenario analysis, see the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (7.02b TTM) > 0 and > 6% of Revenue (6% = 8.18b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 3.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.63% (prev 6.33%; Δ 2.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 17.42b > Net Income 7.02b (YES >=105%, WARN >=100%) |
| Net Debt (66.22b) to EBITDA (16.02b) ratio: 4.13 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (609.2m) change vs 12m ago -2.13% (target <= -2.0% for YES) |
| Gross Margin 15.47% (prev 17.01%; Δ -1.54pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.08% (prev 56.86%; Δ -4.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 18.27 (EBITDA TTM 16.02b / Interest Expense TTM 436.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.25
| (A) 0.04 = (Total Current Assets 93.41b - Total Current Liabilities 81.63b) / Total Assets 261.97b |
| (B) 0.36 = Retained Earnings (Balance) 93.57b / Total Assets 261.97b |
| (C) 0.03 = EBIT TTM 7.96b / Avg Total Assets 261.95b |
| (D) 0.56 = Book Value of Equity 94.18b / Total Liabilities 168.61b |
| Total Rating: 2.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.23
| 1. Piotroski 3.0pt |
| 2. FCF Yield 0.70% |
| 3. FCF Margin 0.65% |
| 4. Debt/Equity 0.92 |
| 5. Debt/Ebitda 4.13 |
| 6. ROIC - WACC (= 1.95)% |
| 7. RoE 7.56% |
| 8. Rev. Trend 8.73% |
| 9. EPS Trend -52.09% |
What is the price of BMW shares?
Over the past week, the price has changed by +8.58%, over one month by +11.87%, over three months by +15.40% and over the past year by +29.55%.
Is BMW a buy, sell or hold?
What are the forecasts/targets for the BMW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90 | -7.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 112.5 | 15.7% |
BMW Fundamental Data Overview December 10, 2025
Market Cap EUR = 59.21b (59.21b EUR * 1.0 EUR.EUR)
P/E Trailing = 8.536
P/E Forward = 7.2622
P/S = 0.4341
P/B = 0.6298
P/EG = 0.5502
Beta = 0.772
Revenue TTM = 136.41b EUR
EBIT TTM = 7.96b EUR
EBITDA TTM = 16.02b EUR
Long Term Debt = 67.01b EUR (from longTermDebt, last quarter)
Short Term Debt = 27.66b EUR (from shortTermDebt, last fiscal year)
Debt = 85.50b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 66.22b EUR (from netDebt column, last fiscal year)
Enterprise Value = 125.46b EUR (59.21b + Debt 85.50b - CCE 19.26b)
Interest Coverage Ratio = 18.27 (Ebit TTM 7.96b / Interest Expense TTM 436.0m)
FCF Yield = 0.70% (FCF TTM 882.0m / Enterprise Value 125.46b)
FCF Margin = 0.65% (FCF TTM 882.0m / Revenue TTM 136.41b)
Net Margin = 5.15% (Net Income TTM 7.02b / Revenue TTM 136.41b)
Gross Margin = 15.47% ((Revenue TTM 136.41b - Cost of Revenue TTM 115.31b) / Revenue TTM)
Gross Margin QoQ = 14.24% (prev 16.43%)
Tobins Q-Ratio = 0.48 (Enterprise Value 125.46b / Total Assets 261.97b)
Interest Expense / Debt = 0.19% (Interest Expense 159.0m / Debt 85.50b)
Taxrate = 27.14% (632.0m / 2.33b)
NOPAT = 5.80b (EBIT 7.96b * (1 - 27.14%))
Current Ratio = 1.14 (Total Current Assets 93.41b / Total Current Liabilities 81.63b)
Debt / Equity = 0.92 (Debt 85.50b / totalStockholderEquity, last quarter 93.36b)
Debt / EBITDA = 4.13 (Net Debt 66.22b / EBITDA 16.02b)
Debt / FCF = 75.08 (Net Debt 66.22b / FCF TTM 882.0m)
Total Stockholder Equity = 92.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.68% (Net Income 7.02b / Total Assets 261.97b)
RoE = 7.56% (Net Income TTM 7.02b / Total Stockholder Equity 92.81b)
RoCE = 4.98% (EBIT 7.96b / Capital Employed (Equity 92.81b + L.T.Debt 67.01b))
RoIC = 4.82% (NOPAT 5.80b / Invested Capital 120.28b)
WACC = 2.87% (E(59.21b)/V(144.72b) * Re(6.82%) + D(85.50b)/V(144.72b) * Rd(0.19%) * (1-Tc(0.27)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.96%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈882.0m ; Y1≈579.1m ; Y5≈264.8m
Fair Price DCF = 9.36 (DCF Value 5.21b / Shares Outstanding 556.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -52.09 | EPS CAGR: -5.59% | SUE: 0.0 | # QB: 0
Revenue Correlation: 8.73 | Revenue CAGR: 3.50% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.72 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=11.31 | Chg30d=-0.190 | Revisions Net=-2 | Growth EPS=+7.0% | Growth Revenue=+2.3%